Editing Ephedrine (section)

====Canada====
In January 2002, [[Health Canada]] issued a voluntary recall of all ephedrine products containing more than 8{{nbsp}}mg per dose, all combinations of ephedrine with other stimulants such as caffeine, and all ephedrine products marketed for weight-loss or bodybuilding indications, citing a serious risk to health.<ref name="health-canada">{{cite web |url = http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2002/2002_01_e.html |title= Health Canada requests recall of certain products containing Ephedra/ephedrine |publisher=[[Health Canada]] |date= January 9, 2002 |access-date= July 7, 2009 |archive-url= https://web.archive.org/web/20070206073244/http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2002/2002_01_e.html |archive-date= February 6, 2007}}</ref> Ephedrine is still sold as an oral nasal decongestant<ref name= "LaccourreyeWerner2015">{{cite journal | vauthors = Laccourreye O, Werner A, Giroud JP, Couloigner V, Bonfils P, Bondon-Guitton E | title = Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants | journal = European Annals of Otorhinolaryngology, Head and Neck Diseases | volume = 132 | issue = 1 | pages = 31–4 | date = February 2015 | pmid = 25532441 | doi = 10.1016/j.anorl.2014.11.001 | doi-access = free }}</ref> in 8{{nbsp}}mg pills as a natural health product, with a limit of 0.4{{spaces}}g (400{{spaces}}mg) per package, the limit established by the Controlled Drugs and Substances Act as it is considered as Class A Precursor.<ref>{{Cite web|author=Legislative Services Branch|date=2021-03-18|title=Consolidated federal laws of canada, Controlled Drugs and Substances Act|url=https://laws-lois.justice.gc.ca/eng/acts/c-38.8/page-18.html|access-date=2021-07-30|website=laws-lois.justice.gc.ca|archive-date=2021-07-30|archive-url=https://web.archive.org/web/20210730190944/https://laws-lois.justice.gc.ca/eng/acts/c-38.8/page-18.html|url-status=dead}}</ref>